137 related articles for article (PubMed ID: 3726798)
1. Heparin-induced platelet aggregation: dose/response relationships for a low molecular weight heparin derivative (PK 10169) and its subfractions.
Brace LD; Fareed J
Thromb Res; 1986 Jun; 42(6):769-82. PubMed ID: 3726798
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced platelet aggregation. II. Dose/response relationships for two low molecular weight heparin fractions (CY 216 and CY 222).
Brace LD; Fareed J
Thromb Res; 1990 Jul; 59(1):1-14. PubMed ID: 2169074
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological studies on the interaction of PK 10169 and its subfractions with human platelets.
Brace LD; Fareed J; Tomeo J; Issleib S
Haemostasis; 1986; 16(2):93-105. PubMed ID: 3710299
[TBL] [Abstract][Full Text] [Related]
4. In vitro coagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169).
Walenga JM; Fareed J; Hoppensteadt DA
Semin Thromb Hemost; 1985 Jan; 11(1):17-25. PubMed ID: 3883497
[TBL] [Abstract][Full Text] [Related]
5. Rationale behind the development of low molecular weight heparin derivatives.
Hirsh J; Ofosu F; Buchanan M
Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
[TBL] [Abstract][Full Text] [Related]
6. Effect of heparin and heparin fractions on platelet aggregation.
Salzman EW; Rosenberg RD; Smith MH; Lindon JN; Favreau L
J Clin Invest; 1980 Jan; 65(1):64-73. PubMed ID: 6243142
[TBL] [Abstract][Full Text] [Related]
7. Molecular weight of heparin versus biologic activity. Some additional considerations.
Losito R; Losito C
Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
[No Abstract] [Full Text] [Related]
8. A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
Vinazzer H; Woler M
Haemostasis; 1986; 16(2):106-15. PubMed ID: 2423420
[TBL] [Abstract][Full Text] [Related]
9. A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment.
Bratt G; Törnebohm E; Lockner D; Bergström K
Thromb Haemost; 1985 Apr; 53(2):208-11. PubMed ID: 4024029
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously.
Bergqvist D; Hedner U; Sjörin E; Holmer E
Thromb Res; 1983 Nov; 32(4):381-91. PubMed ID: 6658720
[TBL] [Abstract][Full Text] [Related]
11. A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
Vinazzer H; Woler M
Thromb Res; 1985 Oct; 40(2):135-46. PubMed ID: 3878009
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans.
Larsson A; Fransson LA; Lewis WE
Thromb Res; 1982 Jun; 26(6):401-9. PubMed ID: 7112518
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of heparin and PK 10169, a low molecular weight fraction, in a canine model of arterial thrombosis.
Mestre M; Clairefond P; Mardiguian J; Trillou M; Le Fur G; Uzan A
Thromb Res; 1985 May; 38(4):389-99. PubMed ID: 4012669
[TBL] [Abstract][Full Text] [Related]
14. On the mechanism of heparin-induced potentiation of platelet aggregation.
Yamamoto M; Watanabe K; Ando Y; Iri H; Handa H; Yoshii Y; Imai M; Sugiura K; Ikeda Y
Thromb Res; 1982 May; 26(3):159-64. PubMed ID: 7112512
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antithrombotic activity of two heparin fragments PK 10169 (mol. wt. 5,000) and EMT 680 (mol. wt. 2,500) and unfractionated heparin in a rabbit experimental thrombosis model: relative importance of systemic anti-Xa and anti-IIa activities.
Bara L; Trillou M; Mardiguian J; Samama M
Nouv Rev Fr Hematol (1978); 1986; 28(6):355-8. PubMed ID: 3562219
[TBL] [Abstract][Full Text] [Related]
16. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
Ellis V; Scully MF; Kakkar VV
Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
[TBL] [Abstract][Full Text] [Related]
17. Heparin, its fractions, fragments and derivatives. Some newer perspectives.
Fareed J
Semin Thromb Hemost; 1985 Jan; 11(1):1-9. PubMed ID: 3919446
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
Hirsh J
Haemostasis; 1986; 16(2):82-6. PubMed ID: 3710297
[TBL] [Abstract][Full Text] [Related]
19. An investigation of the functional role of the carboxylic groups of heparin. Affinity for antithrombin III and anti-Xa activity of selectively carboxyl esterified heparin.
Mardiguian J; Trillou M
Semin Thromb Hemost; 1985 Jan; 11(1):34-6. PubMed ID: 3975640
[No Abstract] [Full Text] [Related]
20. Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers.
Mätzsch T; Bergqvist D; Hedner U; Ostergaard P
Thromb Haemost; 1987 Feb; 57(1):97-101. PubMed ID: 3590085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
